All In Biotech

Free tool

FAERS Monitor: Qlonilik

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 221094 or its brand name (Qlonilik, Clonidine Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

5,651

Serious

3,859

68% of reports

Hospitalization

1,611

Death reported

915

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hypertension762
  • headache711
  • off label use658
  • pain638
  • fatigue634
  • hypersensitivity549
  • drug ineffective523
  • nausea476
  • infusion related reaction442
  • hepatic enzyme increased436
  • joint swelling425
  • rash411
  • dyspnoea386
  • prescribed overdose374
  • diarrhoea369

Reports by year received

View as table
YearReports
20041
20055
20066
200710
200822
20098
201065
2011111
2012102
201367
201472
2015110
2016117
2017244
2018236
2019221
2020261
2021329
2022617
2023649
2024894
2025895
2026608

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,048,508 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
prescribed overdoseSignal37473.366.426,121
infusion related reactionSignal44225.022.810,114
hepatic enzyme increasedSignal43623.921.99,535
hypertensionSignal76213.412.68,816
joint swellingSignal42513.112.04,768
hypersensitivitySignal54911.010.25,031
headacheSignal7114.23.91,798
painSignal6383.93.61,394
rashSignal4113.53.2751
fatigueSignal6343.02.8894
off label useSignal6582.82.6791
dyspnoeaSignal3862.52.3368
nauseaSignal4762.22.1338
diarrhoeaSignal3692.11.9226
drug ineffective5231.51.485

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.